{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:20:52Z","timestamp":1768972852017,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.psychres.2007.04.016","type":"journal-article","created":{"date-parts":[[2007,11,30]],"date-time":"2007-11-30T12:30:01Z","timestamp":1196425801000},"page":"123-129","source":"Crossref","is-referenced-by-count":14,"title":["Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy"],"prefix":"10.1016","volume":"157","author":[{"given":"Linda L.","family":"Carpenter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Bayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchel A.","family":"Kling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence H.","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey R.","family":"Tyrka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Becky","family":"Kinkead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles B.","family":"Nemeroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2007.04.016_bib1","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0031-9384(96)00156-4","article-title":"Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test","volume":"60","author":"Aguiar","year":"1996","journal-title":"Physiology and Behavior"},{"key":"10.1016\/j.psychres.2007.04.016_bib2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0006-8993(86)91514-3","article-title":"Regional distribution of neuropeptide K and other tachykinins (neurokinin A, neurokinin B and substance P) in rat central nervous system","volume":"399","author":"Arai","year":"1986","journal-title":"Brain Research"},{"key":"10.1016\/j.psychres.2007.04.016_bib3","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0006-3223(85)90193-3","article-title":"CSF substance P immunoreactivity in affective disorders","volume":"20","author":"Berrettini","year":"1985","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2007.04.016_bib4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0006-3223(02)01544-5","article-title":"Substance P serum levels are increased in major depression: preliminary results","volume":"53","author":"Bondy","year":"2003","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2007.04.016_bib5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.biopsych.2004.06.025","article-title":"Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients","volume":"56","author":"Carpenter","year":"2004","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2007.04.016_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/sj.npp.1300045","article-title":"A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders","volume":"28","author":"Commons","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2007.04.016_bib7","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1139\/y95-122","article-title":"Central tachykinins: mediators of defence reaction and stress reactions","volume":"73","author":"Culman","year":"1995","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"10.1016\/j.psychres.2007.04.016_bib8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/32904","article-title":"Altered nociception, analgesia and aggression in mice lacking the receptor for substance P","volume":"392","author":"De Felipe","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.psychres.2007.04.016_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2004.12.007","article-title":"Substance P in serum and cerebrospinal fluid of depressed patients: no effect of antidepressant treatment","volume":"136","author":"Deuschle","year":"2005","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2007.04.016_bib10","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1073\/pnas.0400794101","article-title":"Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats","volume":"101","author":"Ebner","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.psychres.2007.04.016_bib11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF00248227","article-title":"Place aversion induced by the substance P analogue, dimethyl-C7, is not state dependent: implication of substance P in aversion","volume":"73","author":"Elliott","year":"1988","journal-title":"Experimental Brain Research"},{"key":"10.1016\/j.psychres.2007.04.016_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0196-9781(01)00592-7","article-title":"Investigation of substance P transport across the blood\u2013brain barrier","volume":"23","author":"Freed","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.psychres.2007.04.016_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.biopsych.2005.07.028","article-title":"A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression","volume":"58","author":"George","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2007.04.016_bib14","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1176\/appi.ajp.163.4.637","article-title":"Elevated cerebrospinal fluid substance P concentrations in post-traumatic stress disorder and major depression","volume":"163","author":"Geracioti","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2007.04.016_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2003.11.064","article-title":"Mechanisms of action of the antidepressants fluoxetine and the substance P antagonist L-000760735 are associated with altered neurofilaments and synaptic remodeling","volume":"1002","author":"Guest","year":"2004","journal-title":"Brain Research"},{"key":"10.1016\/j.psychres.2007.04.016_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0006-3223(01)01162-3","article-title":"Sustained blockade of neurokinin-1 receptors enhances serotonin neurotransmission","volume":"50","author":"Haddjeri","year":"2001","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2007.04.016_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1016\/j.psychres.2007.04.016_bib18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1357-2725(01)00031-0","article-title":"Substance p","volume":"33","author":"Harrison","year":"2001","journal-title":"International Journal of Biochemistry and Cell Biology"},{"key":"10.1016\/j.psychres.2007.04.016_bib19","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/WNL.59.6_suppl_4.S3","article-title":"Therapeutic mechanisms of vagus nerve stimulation","volume":"59","author":"Henry","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.psychres.2007.04.016_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.0954-6820.2000.00773.x","article-title":"Substance P: a pioneer amongst neuropeptides","volume":"249","author":"Hokfelt","year":"2001","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.psychres.2007.04.016_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1385\/JMN:25:3:239","article-title":"Corticotropin-releasing factor mRNA and substance P receptor binding in the paraventricular hypothalamic nucleus, central nucleus of the amygdala, and locus coeruleus of Sprague\u2013Dawley rats following restraint-induced stress","volume":"25","author":"Hwang","year":"2005","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1016\/j.psychres.2007.04.016_bib22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/10253890009001125","article-title":"Substance P is involved in terminating the hypothalamo\u2013pituitary\u2013adrenal axis response to acute stress through centrally located neurokinin-1 receptors","volume":"3","author":"Jessop","year":"2000","journal-title":"Stress"},{"key":"10.1016\/j.psychres.2007.04.016_bib23","first-page":"108","article-title":"Some observations indicating a low brain uptake of [3H]Nle11-Substance P","volume":"38","author":"Landgraf","year":"1983","journal-title":"Pharmazie"},{"key":"10.1016\/j.psychres.2007.04.016_bib24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0006-8993(02)02476-9","article-title":"The selective neurokinin (NK)(1) antagonist, GR205,171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electrophysiological study","volume":"935","author":"Lejeune","year":"2002","journal-title":"Brain Research"},{"key":"10.1016\/j.psychres.2007.04.016_bib25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-2004-832599","article-title":"Serum levels of substance P and response to antidepressant pharmacotherapy","volume":"37","author":"Lieb","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psychres.2007.04.016_bib26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-8993(84)90470-0","article-title":"Substance P receptors: localization by light microscopic autoradiography in rat brain using [3H]SP as the radioligand","volume":"307","author":"Mantyh","year":"1984","journal-title":"Brain Research"},{"key":"10.1016\/j.psychres.2007.04.016_bib27","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1600-0447.1989.tb10307.x","article-title":"Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid","volume":"79","author":"Martensson","year":"1989","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.psychres.2007.04.016_bib28","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2174\/1381612053764779","article-title":"Do substance P and the NK1 receptor have a role in depression and anxiety?","volume":"11","author":"McLean","year":"2005","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.psychres.2007.04.016_bib29","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1046\/j.1471-4159.2001.00211.x","article-title":"Selective blockade of neurokinin (NK)(1) receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats","volume":"76","author":"Millan","year":"2001","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.psychres.2007.04.016_bib30","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.biopsych.2005.04.049","article-title":"Changes in hypothalamic\u2013pituitary\u2013adrenal axis measures after vagus nerve stimulation therapy in chronic depression","volume":"58","author":"O'Keane","year":"2005","journal-title":"Biological Psychiatry"},{"issue":"Suppl 12","key":"10.1016\/j.psychres.2007.04.016_bib31","first-page":"5","article-title":"Specific characteristics of the pain\/depression association in the general population","volume":"65","author":"Ohayon","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2007.04.016_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archpsyc.60.1.39","article-title":"Using chronic pain to predict depressive morbidity in the general population","volume":"60","author":"Ohayon","year":"2003","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2007.04.016_bib33","first-page":"1","article-title":"Studies on substance P; purification, occurrence and biological actions","volume":"29","author":"Pernow","year":"1953","journal-title":"Acta Physiologica Scandinavica. Supplementum"},{"key":"10.1016\/j.psychres.2007.04.016_bib34","first-page":"509","article-title":"Elevation of substance P-like peptides in the CSF of psychiatric patients","volume":"19","author":"Rimon","year":"1984","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2007.04.016_bib35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biopsych.2005.05.025","article-title":"Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial","volume":"58","author":"Rush","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2007.04.016_bib36","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1017\/S1092852900018861","article-title":"Substance P antagonists: meet the new drugs, same as the old drugs? Insights from transgenic animal models","volume":"8","author":"Santarelli","year":"2003","journal-title":"CNS Spectrums"},{"key":"10.1016\/j.psychres.2007.04.016_bib37","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1073\/pnas.041596398","article-title":"Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function","volume":"98","author":"Santarelli","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.psychres.2007.04.016_bib38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-8993(96)00812-8","article-title":"Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the rat","volume":"739","author":"Shirayama","year":"1996","journal-title":"Brain Research"},{"key":"10.1016\/j.psychres.2007.04.016_bib39","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1146\/annurev.pharmtox.41.1.877","article-title":"Neurokinin(1) receptor antagonists as potential antidepressants","volume":"41","author":"Stout","year":"2001","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.psychres.2007.04.016_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0014-2999(96)00390-1","article-title":"Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice","volume":"311","author":"Teixeira","year":"1996","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.psychres.2007.04.016_bib41","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1113\/jphysiol.1931.sp002763","article-title":"An unidentified depressor substance in certain tissue extracts","volume":"72","author":"von Euler","year":"1931","journal-title":"Journal of Physiology"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178107001242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178107001242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T21:36:43Z","timestamp":1708378603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178107001242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":41,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0165178107001242"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2007.04.016","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}